Search for: "Gilead Sciences, Inc. v. Merck "
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
26 Sep 2018, 6:00 pm
by Dennis Crouch Merck & Co., Inc. v. [read post]
19 Jan 2016, 3:56 pm
Gilead Sciences, Inc. v. [read post]
27 Feb 2018, 12:24 pm
E.g., Orthokinetics, Inc. v. [read post]
3 Apr 2019, 5:15 am
Moreover, the Federal Circuit, in Gilead Sciences, Inc. v. [read post]
13 Jan 2016, 6:43 am
" Gilead Sciences, Inc. v. [read post]
11 Oct 2018, 12:57 am
Eszter SzakácsCo-author: Zsolt Lengyel, Danubia Patent and Law Office Just a few months before the CJEU’s judgment in C-121/17 Teva UK Ltd and Others v Gilead Sciences Inc. came out a the Metropolitan Court of Budapest handed down a decision regarding Merck Sharp and Dohme Corp’s (MSD) application for an SPC re the combination of ezetimibe and rosuvastatin. [read post]
23 Oct 2018, 2:00 pm
Inc. v. [read post]
5 Sep 2023, 2:39 am
Cellect Strategies Some stakeholders have been expecting a decision like Cellect since the Federal Circuit first decided that a later-granted patent can raise OTDP issues for an earlier-granted patent, in its 2014 decision in Gilead Sciences, Inc. v. [read post]
7 Dec 2014, 3:29 pm
‘It’s Idenix Pharmaceutical, Inc v Gilead Sciences, Inc & Others [2014] EWHC 3916 (Pat) (01 December 2014)’, Darren might answer. [read post]
7 Sep 2011, 4:22 am
General 10 considerations in a life sciences license (Richard C. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
22 Dec 2014, 3:41 am
As Shalini Bengani explains in this post,TufAmerica Inc v W B Music Corp 13-cv-7847(LAK), decided by the US District Court for the Southern District of New York, is another one of those cases. [read post]
15 Dec 2014, 7:25 am
* Oracle v Google: are certain elements of the Java platform entitled to copyright protection? [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
